Supplementary Table S1 from FDA Approval Summary: Erdafitinib for FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma
Authors:
- William F. MaguireWMWilliam F. Maguire
- Elaine ChangECElaine Chang
- Flora MulkeyFMFlora Mulkey
- Vicky HsuVHVicky Hsu
- Huali WuHWHuali Wu
- Tien M. TruongTTTien M. Truong
- Dana KappelDKDana Kappel
- Jeffrey KraftJKJeffrey Kraft
- Jingyu YuJYJingyu Yu
- Xin GaoXGXin Gao
- William F. PierceWPWilliam F. Pierce
- Nam Atiqur RahmanNRNam Atiqur Rahman
Open Access
- 15 October 2026
- other
- Published by American Association for Cancer Research (AACR)